291 related articles for article (PubMed ID: 31426381)
1. The Role of the
Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
[TBL] [Abstract][Full Text] [Related]
2. [Expression of HoxA10 in acute leukemia and its significance].
Huang Y; Li WJ; Wei CX; Zhou Z; Nie B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):959-63. PubMed ID: 16403259
[TBL] [Abstract][Full Text] [Related]
3. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression.
Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM
Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
6. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
7. The expression and regulation of HOX genes and membrane proteins among different cytogenetic groups of acute myeloid leukemia.
Wang H; Lin SY; Hu FF; Guo AY; Hu H
Mol Genet Genomic Med; 2020 Sep; 8(9):e1365. PubMed ID: 32614525
[TBL] [Abstract][Full Text] [Related]
8. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
Xu P; Zhou D; Yan G; Ouyang J; Chen B
Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells.
Ghasemi R; Struthers H; Wilson ER; Spencer DH
Leukemia; 2021 Feb; 35(2):404-416. PubMed ID: 32398790
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
12. CTCF boundary remodels chromatin domain and drives aberrant
Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
[No Abstract] [Full Text] [Related]
13. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.
Spencer DH; Young MA; Lamprecht TL; Helton NM; Fulton R; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Miller CA; Klco JM; Wilson RK; Ley TJ
Leukemia; 2015 Jun; 29(6):1279-89. PubMed ID: 25600023
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
Feng Y; Hu S; Li L; Peng X; Chen F
Cell Death Dis; 2020 Dec; 11(12):1025. PubMed ID: 33268767
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.
Chen SL; Hu F; Wang DW; Qin ZY; Liang Y; Dai YJ
Aging (Albany NY); 2020 Jun; 12(12):11864-11877. PubMed ID: 32568101
[TBL] [Abstract][Full Text] [Related]
17. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
Zhang Q; Han Q; Zi J; Song C; Ge Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
[TBL] [Abstract][Full Text] [Related]
18. An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis.
Jung N; Dai B; Gentles AJ; Majeti R; Feinberg AP
Nat Commun; 2015 Oct; 6():8489. PubMed ID: 26444494
[TBL] [Abstract][Full Text] [Related]
19. HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy.
Dickson GJ; Liberante FG; Kettyle LM; O'Hagan KA; Finnegan DP; Bullinger L; Geerts D; McMullin MF; Lappin TR; Mills KI; Thompson A
Haematologica; 2013 Aug; 98(8):1216-25. PubMed ID: 23539541
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
